http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10218771-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5736c85c1929ce4e9775e836a65d6c05 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 |
| filingDate | 1997-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2896ffdfb3c12fa1a6fa47f161b7c4ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_056fac6d45ae0665fc6bedc1199a04e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f380e3c5e53298d36680fc740bc6d392 |
| publicationDate | 1998-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H10218771-A |
| titleOfInvention | Platelet-derived vascular endothelial cell growth factor activity inhibitor containing pyrazolone compound or salt thereof |
| abstract | (57) [Abstract] (Modified) [PROBLEMS] An inhibitory compound for a protein involved in nucleic acid synthesis / metabolism and angiogenesis in a living body, further comprising malignant tumor, cancer metastasis, diabetic retinopathy, rheumatoid arthritis, Provided is a platelet-derived vascular endothelial cell growth factor activity inhibitor containing a pyrazolone compound or a salt thereof, which is useful for prevention and treatment of diseases associated with abnormal blood vessel growth such as psoriasis. SOLUTION: General formula (I): (In the formula, R 1 is an optionally substituted alkyl group, an optionally substituted alkylthio group, an optionally substituted cycloalkyl group, an optionally substituted phenyl group, an optionally substituted pyridinyl group, and the like. , R 2 is a hydrogen atom, a halogen atom, a hydroxy group, a carboxy group, a cyano group, an alkyl group which may be substituted, etc.) or a salt thereof. Endothelial cell growth factor activity inhibitor. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4629993-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1297849-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1297849-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005012255-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7638516-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005289874-A |
| priorityDate | 1997-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 427.